Undergraduate - UnitPHA3042 - Modern drug development

This unit entry is for students who completed this unit in 2013 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 2, 0.125 EFTSL

To find units available for enrolment in the current year, you must make sure you use the indexes and browse unit tool in the current edition of the Handbook.

Level	Undergraduate
Faculty	Faculty of Science
Offered	Clayton Second semester 2013 (Day)
Coordinator(s)	Dr Barbara Kemp-Harper and Dr Eva Patak

Synopsis

Modern drug development will provide the student with an appreciation of the process of discovery, testing, approval and marketing of new drugs. This will include the diseases most likely to be targeted by pharmaceutical companies for drug development; the technical issues underlying drug discovery; the role of genomics in identifying novel targets; rational drug design; the importance of screens including molecular models and high throughput screening; disease models; case studies illustrating the successful development of drugs. Career opportunities in all aspects of drug development will be highlighted.

Outcomes

On completion of this unit students will be able to:

Discuss the steps involved in the drug discovery process, including sources of drugs, how targets are identified and screening processes that can be used to test for desired activity;

Discuss the steps involved in developing a commercial product from a potential drug candidate, including the relevant regulatory framework and marketing considerations;

Describe the approaches to the development of new therapies for neglected and emerging diseases;

Demonstrate the ability to critically evaluate methodologies and data from experiments in the context of the drug development process;

Demonstrate the ability to obtain, present and interpret data from pharmacological experiments relevant to the area of drug development;

Demonstrate the ability to source and critically evaluate the scientific literature to address an issue in the area of drug development and to communicate this orally, in written form or via a poster presentation;

Demonstrate the ability to work both independently and as part of a team.

Assessment

Examination (2 hours): 60%
Written assignment: 16%
Practical exercises and written reports: 24%

Chief examiner(s)

Dr Emma Jones

Contact hours

Two 1-hour lectures and three hours of laboratory or self-directed learning/ tutorial per week.

Prerequisites

PHA3011 and one of PHA3021 or BMS3021